litlas
ログインアカウント作成

John Bryant

1968–2025 年に発表

67
論文数
39,989
被引用数
49
h 指数
60
i10 指数

被引用数

John Bryant の年別被引用数1969 年: 被引用 3 件1970 年: 被引用 2 件1974 年: 被引用 1 件1977 年: 被引用 3 件1978 年: 被引用 1 件1979 年: 被引用 1 件1980 年: 被引用 1 件1981 年: 被引用 2 件1983 年: 被引用 2 件1984 年: 被引用 1 件1986 年: 被引用 3 件1988 年: 被引用 4 件1990 年: 被引用 1 件1991 年: 被引用 3 件1992 年: 被引用 2 件1993 年: 被引用 9 件1994 年: 被引用 3 件1995 年: 被引用 16 件1996 年: 被引用 11 件1997 年: 被引用 17 件1998 年: 被引用 51 件1999 年: 被引用 55 件2000 年: 被引用 84 件2001 年: 被引用 134 件2002 年: 被引用 114 件2003 年: 被引用 175 件2004 年: 被引用 192 件2005 年: 被引用 287 件2006 年: 被引用 361 件2007 年: 被引用 427 件2008 年: 被引用 433 件2009 年: 被引用 443 件2010 年: 被引用 411 件2011 年: 被引用 368 件2012 年: 被引用 316 件2013 年: 被引用 340 件2014 年: 被引用 262 件2015 年: 被引用 256 件2016 年: 被引用 216 件2017 年: 被引用 184 件2018 年: 被引用 203 件2019 年: 被引用 649 件2020 年: 被引用 651 件2021 年: 被引用 548 件2022 年: 被引用 421 件2023 年: 被引用 283 件2024 年: 被引用 449 件2025 年: 被引用 170 件2026 年: 被引用 8 件1971〜1973 年は被引用が無いため表示していません1975〜1976 年は被引用が無いため表示していません1982 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,816 件、この内訳の 33.2%イギリス: 引用元論文 859 件、この内訳の 7.5%イタリア: 引用元論文 607 件、この内訳の 5.3%中国: 引用元論文 584 件、この内訳の 5.1%ドイツ: 引用元論文 567 件、この内訳の 4.9%カナダ: 引用元論文 549 件、この内訳の 4.8%フランス: 引用元論文 387 件、この内訳の 3.4%オランダ: 引用元論文 376 件、この内訳の 3.3%スイス: 引用元論文 315 件、この内訳の 2.7%スペイン: 引用元論文 266 件、この内訳の 2.3%オーストラリア: 引用元論文 257 件、この内訳の 2.2%ベルギー: 引用元論文 256 件、この内訳の 2.2%
0%33.2%その他 23.1%

機関

分野

  • Biochemistry, Genetics and Molecular Biology46.6%
  • Medicine41%
  • Immunology and Microbiology2.7%
  • Computer Science2.3%
  • Economics, Econometrics and Finance1.4%
  • Engineering1%
  • その他5%

トピック

  • Breast Cancer Treatment Studies14.8%
  • HER2/EGFR in Cancer Research6.3%
  • Breast Lesions and Carcinomas5.9%
  • Breast Implant and Reconstruction3.7%
  • Cancer Genomics and Diagnostics2.5%
  • Estrogen and related hormone effects2.4%
  • その他64.4%

共著者

全論文

検索で開く
  1. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    著者: Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark - New England Journal of Medicine 2004 被引用: 6,358

  2. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    著者: Bernard Asselain, William E. Barlow, John M.S. Bartlett, Jonas Bergh, Elizabeth Bergsten-Nordström, Judith M. Bliss, Francesco Boccardo, Clare Boddington, Jan Bogaerts, Gianni Bonadonna, Rosie Bradley, Étienne Brain, Jeremy Braybrooke, Philippe Broët, John Bryant, Julie Ann Burrett, David Cameron, Mike Clarke, Alan S. Coates, Robert L. Coleman, Raoul Charles Coombes, Candace R. Correa, Joe Costantino, Jack Cuzick, David N. Danforth, Nancy E. Davidson, Christina Davies, Lucy Davies, Angelo Di Leo, David Dodwell, Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz ほか 10 名 - The Lancet Oncology 2017 被引用: 1,133

  3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    著者: Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark - New England Journal of Medicine 2005 被引用: 5,353

  4. Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

    著者: Bernard Fisher, Stewart Anderson, John Bryant, Richard G. Margolese, Melvin Deutsch, Edwin R. Fisher, Jong‐Hyeon Jeong, Norman Wolmark - New England Journal of Medicine 2002 被引用: 6,228

  5. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

    著者: Paul W. Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin, Eric Nesbit, Tim J. Kruser, Jason W. Chan, Steve Braunstein, Jessica Lee, John P. Kirkpatrick, Will Breen, Paul D. Brown, Diana D. Shi, Helen A. Shih, Hany Soliman, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Ashlyn S. Everett, Drexell H. Boggs, Laura Masucci, David Roberge, Jill Remick, Kristin A. Plichta, John M. Buatti, Supriya Jain, Laurie E. Gaspar, Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, Yi An, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - Journal of Clinical Oncology 2020 被引用: 467

  6. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    著者: Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2006 被引用: 2,577

  7. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

    著者: Frank A. Vicini, Reena S. Cecchini, Julia White, Douglas W. Arthur, Thomas B. Julian, Rachel Rabinovitch, Robert R. Kuske, Patricia A. Ganz, David S. Parda, Michael F. Scheier, Kathryn Winter, Soonmyung Paik, Henry M. Kuerer, Laura A. Vallow, Lori J. Pierce, Eleftherios P. Mamounas, Beryl McCormick, Joseph P. Costantino, Harry D. Bear, Isabelle Germain, G.S. Gustafson, Linda Grossheim, Ivy A. Petersen, Richard Hudes, Walter J. Curran, John Bryant, Norman Wolmark - The Lancet 2019 被引用: 475

  8. Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

    著者: Bernard Fisher, Jong‐Hyeon Jeong, Stewart Anderson, John Bryant, Edwin R. Fisher, Norman Wolmark - New England Journal of Medicine 2002 被引用: 1,386

  9. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

    著者: Bernard Fisher, John Bryant, Norman Wolmark, E.P. Mamounas, A Brown, Edwin R. Fisher, D. Lawrence Wickerham, Mirsada Begovič, Arthur P. DeCillis, A Robidoux, Richard G. Margolese, Anatolio B. Cruz, James L. Hoehn, Alan Lees, N V Dimitrov, Harry D. Bear - Journal of Clinical Oncology 1998 被引用: 2,192

  10. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

    著者: Elizabeth Tan-Chiu, Greg Yothers, Edward H. Romond, Charles E. Geyer, Michael S. Ewer, Deborah Keefe, Richard P. Shannon, Sandra M. Swain, Ann Brown, Louis Fehrenbacher, Victor G. Vogel, Thomas E. Seay, Priya Rastogi, Eleftherios P. Mamounas, Norman Wolmark, John Bryant - Journal of Clinical Oncology 2005 被引用: 807

  11. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today

    著者: Paul W. Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin, Eric Nesbit, Tim J. Kruser, Jason W. Chan, Steve Braunstein, Jessica Lee, John P. Kirkpatrick, Will Breen, Paul D. Brown, Diana D. Shi, Helen A. Shih, Hany Soliman, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Ashlyn S. Everett, Drexell H. Boggs, Laura Masucci, David Roberge, Jill Remick, Kristin A. Plichta, John M. Buatti, Supriya Jain, Laurie E. Gaspar, Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, James B. Yu, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - International Journal of Radiation Oncology*Biology*Physics 2020 被引用: 147

  12. Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less

    著者: Bernard Fisher, John Bryant, James J. Dignam, D. Lawrence Wickerham, Eleftherios P. Mamounas, Edwin R. Fisher, Richard G. Margolese, Lois Nesbitt, Soonmyung Paik, Thomas M. Pisansky, Norman Wolmark - Journal of Clinical Oncology 2002 被引用: 696

  13. Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

    著者: Eleftherios P. Mamounas, John Bryant, Barry C. Lembersky, Louis Fehrenbacher, Scot Sedlacek, Bernard Fisher, D. Lawrence Wickerham, Greg Yothers, Atilla Soran, Norman Wolmark - Journal of Clinical Oncology 2005 被引用: 714

  14. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

    著者: Markus Maeurer, Susanne M. Gollin, D Martin, William Swaney, John Bryant, Chiara Castelli, Paul D. Robbins, Giorgio Parmiani, Walter J. Storkus, M T Lotze - Journal of Clinical Investigation 1996 被引用: 286

  15. Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

    著者: William P. Hausdorff, John Bryant, Peter R. Paradiso, George R. Siber - Clinical Infectious Diseases 2000 被引用: 872

  16. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival

    著者: Paul W. Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin, Eric Nesbit, Tim J. Kruser, Jason W. Chan, Steve Braunstein, Jessica Lee, John P. Kirkpatrick, Will Breen, Paul D. Brown, Diana D. Shi, Helen A. Shih, Hany Soliman, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Ashlyn S. Everett, Drexell H. Boggs, Laura Masucci, David Roberge, Jill Remick, Kristin A. Plichta, John M. Buatti, Supriya Jain, Laurie E. Gaspar, Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, James B. Yu, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - Neuro-Oncology 2020 被引用: 77

  17. Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer

    著者: Mitchell H. Gail, Joseph P. Costantino, John Bryant, Robert T. Croyle, Laurence S. Freedman, Kathy J. Helzlsouer, Victor G. Vogel - JNCI Journal of the National Cancer Institute 1999 被引用: 671

  18. Pathobiology of preoperative chemotherapy

    著者: Edwin R. Fisher, Jiping Wang, John Bryant, Bernard Fisher, Eletherios Mamounas, Norman Wolmark - Cancer 2002 被引用: 413

  19. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

    著者: Bernard Fisher, Jong‐Hyeon Jeong, John Bryant, Stewart Anderson, James J. Dignam, Edwin R. Fisher, Norman Wolmark - The Lancet 2004 被引用: 360

  20. Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials

    著者: John Bryant, Roger Day - Biometrics 1995 被引用: 261

  21. American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

    著者: Eric P. Winer, Clifford A. Hudis, Harold J. Burstein, Antonio C. Wolff, Kathleen I. Pritchard, James N. Ingle, Rowan T. Chlebowski, Richard D. Gelber, S.B. Edge, Julie R. Gralow, Melody Cobleigh, Eleftherios P. Mamounas, Lori J. Goldstein, Timothy J. Whelan, Trevor J. Powles, John Bryant, Cheryl Perkins, Judy Perotti, Susan Braun, Amy S. Langer, George P. Browman, Mark R. Somerfield - Journal of Clinical Oncology 2004 被引用: 1,034

  22. Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials

    著者: Alphonse G. Taghian, Jong‐Hyeon Jeong, Eleftherios P. Mamounas, Stewart Anderson, John Bryant, Melvin Deutsch, Norman Wolmark - Journal of Clinical Oncology 2004 被引用: 381

  23. NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial

    著者: David N. Krag, Thomas B. Julian, Seth P. Harlow, Donald L. Weaver, Taka Ashikaga, John Bryant, Richard M. Single, Norman Wolmark - Annals of Surgical Oncology 2004 被引用: 109

  24. Estrogen Receptor Status of Primary Breast Cancer Is Predictive of Estrogen Receptor Status of Contralateral Breast Cancer

    著者: Sandra M. Swain, John Wilson, Eleftherios P. Mamounas, John Bryant, D. Lawrence Wickerham, Bernard Fisher, Soon Young Paik, Norman Wolmark - JNCI Journal of the National Cancer Institute 2004 被引用: 105